At the end of the day you can try and bully and intimidate people into not posting negative comments about the company all you want, many of them are warranted, it won't make any difference.
Management is failing to communicate and keep shareholders informed, when was the last information supplied to shareholders. They learnt about the FDA application through media reports, nothing from the company then nothing since, same with sales, same with China recert.
A classic example is posters this week informing the forumn that the new formulation and packaging had hit the market, surely this was worthy of a ASX market release especially seeing a number of brokers in the past has highlighted that a2m were slipping behind in keeping up with other market players with progressing the formulation to meet customer needs.
So instead of blaming everyone else maybe look within.
A2M Price at posting:
$4.30 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)